Head of Investor Relations
Apellis Pharmaceuticals, Inc.
Equibles does not estimate personal net worth.
Meredith Kaya is recorded as Head of Investor Relations at Apellis Pharmaceuticals, Inc.. Meredith Kaya has spoken on 9 earnings calls across 1 company, most recently for Apellis Pharmaceuticals, Inc. on September 30, 2024. Apellis Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“Good morning, and thank you for joining us to discuss Apellis' third quarter 2024 financial results. With me on the call are Co-Founder and Chief Executive Officer, Dr. Cedric Francois; Chief Operating Officer, Adam Townsend; Chief Medical Officer, Dr. Caroline Baumal; and Chief Financial Officer, Tim Sullivan.”
“Good morning, and thank you for joining us to discuss Apellis second quarter 2024 financial results. With me on the call are Co-Founder and Chief Executive Officer, Dr. Cedric Francois; Chief Operating Officer, Adam Townsend; Chief Medical Officer, Dr. Caroline Baumal; and Chief Financial Officer, Tim Sullivan.”
“Good morning, and thank you for joining us to discuss Apellis' First Quarter 2024 financial results. With me on the call are: Co-Founder and Chief Executive Officer, Dr. Cedric Francois; Chief Operating Officer, Adam Townsend; Chief Medical Officer, Dr. Caroline Baumal, and Chief Financial Officer, Tim Sullivan.”
“Good morning and thank you for joining us to discuss Apellis' fourth quarter and full year 2023 financial results.”
“Good morning and thank you for joining us to discuss Apellis' third quarter 2023 financial results. With me on the call are Co-Founder and Chief Executive Officer Dr. Cedric Francois; Chief Commercial Officer, Adam Townsend; Chief Medical Officer, Dr. Caroline Baumal; and Chief Financial Officer, Tim Sullivan.”
Apellis Pharmaceuticals, Inc.
Head of Investor Relations
Source not stated
Apellis Pharmaceuticals, Inc.
Biotechnology · Healthcare
Head of Investor Relations
Apellis Pharmaceuticals, Inc. Q3 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Q2 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Q1 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Q4 FY2023 Earnings Call
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Q3 FY2023 Earnings Call
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Q3 FY2022 Earnings Call
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Q1 FY2022 Earnings Call
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Q4 FY2021 Earnings Call
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Q3 FY2021 Earnings Call
Apellis Pharmaceuticals, Inc.
